Co-Diagnostics, Inc. - CODX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | Armistice Capital, LLC | 9.99% | 559,706 | View |
| Aug 14, 2026 | SCHEDULE 13G | Steven Boyd | 9.99% | 559,706 | View |
| Aug 10, 2026 | SCHEDULE 13G/A | JANE STREET GROUP, LLC | 1.7% | 89,240 | View |
| Aug 10, 2026 | SCHEDULE 13G/A | Jane Street Capital, LLC | 0.6% | 30,543 | View |
| Aug 10, 2026 | SCHEDULE 13G/A | Jane Street Global Trading, LLC | 1.1% | 58,697 | View |
| Jun 03, 2026 | SCHEDULE 13G | JANE STREET GROUP, LLC | 6.4% | 236,359 | View |
| Jun 03, 2026 | SCHEDULE 13G | Jane Street Capital, LLC | 5.2% | 189,817 | View |
| Jun 03, 2026 | SCHEDULE 13G | Jane Street Global Trading, LLC | 1.3% | 46,542 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.